CoreBone Information

CoreBone is an orthopedic regenerative medicine company addressing a critical gap in cartilage repair: the inability to regenerate both articular cartilage and subchondral bone. Its proprietary, IP‑protected implant is designed as a single‑procedure, off‑the‑shelf solution that enables structural and functional joint tissue regeneration without cell therapy or repeat surgeries. The technology is built on a scalable, coral‑derived biomaterial platform that has been clinically and commercially validated through international dental bone graft distribution, including regulatory approval in China. Preclinical studies demonstrate superior regenerative outcomes versus current standards of care, substantially reducing technical and translational risk. With a defined regulatory pathway and reduced preclinical risk profile, CoreBone is entering First‑in‑Human clinical trials, targeting a large global orthopedic market with significant unmet need.